Regulations.gov document
Testing for Biotin Interference in In Vitro Diagnostic Devices; Draft Guidance for…
Notice · FDA-2019-D-1876 · posted Jun 14, 2019
Key facts
| Document ID | FDA-2019-D-1876-0001 |
|---|---|
| Title | Testing for Biotin Interference in In Vitro Diagnostic Devices; Draft Guidance for Industry; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2019-D-1876 |
| Posted | Jun 14, 2019 |
| Federal Register citation | 84 FR 27781 |
| FR document number | 2019-12564 |
| Comment period opens | Jun 14, 2019 |
| Comments due | Aug 14, 2019 |
| Effective date | Jun 14, 2019 |
At a glance
- 1–9 Pages
- No Open for comment
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: